Divalproex Sodium
Product Images NDC 67046-138

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 67046-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium (Divalprodrplr Figure 01)

FDA Label Image

Divalproex Sodium Dr Tablets (Divalprodrplr Figure 02)

FDA Label Image

Divalproex Sodium Dr Tablets (Divalprodrplr Figure 03)

FDA Label Image

Divalproex Sodium Dr Tablets (Divalprodrplr Figure 04)

This appears to be a chart showing the reduction in CP8 Auto in patients with varying percentages. The chart shows the percentage reduction in CP8 Auto from 100% to 0%, with corresponding levels of x, 1], £, and no charge. There are also high and low dose options, and the chart indicates the percentages of patients who experience a reduction in CP8 Auto in each category.*

FDA Label Image

Divalproex Sodium Dr Tablets (Divalprodrplr Figure 05)

FDA Label Image

Divalproex Sodium Delayed-release Tablets Usp, 250 mg (Divalprodrplr Figure 07)

This is a description of a medication called Divalproex Sodium. It comes in tablet form and has a strength of 250mg. The package contains 30 tablets and is intended for prescription use only. The batch code is MN6569 and the pill identifier is ZAQ7. The package should be stored in a moderate temperature environment between 20-25°C (68-77°F) as specified by the USP Controlled Room Temperature requirements. The manufacturer is Zydus and it was packaged by Contract Pharmacy Services-PA. The package insert contains detailed prescribing information including usual dosage instructions. The medication is a USP equivalent to valproic acid.*

FDA Label Image

Divalproex Sodium Delayed-release Tablets Usp, 500 mg (Divalprodrplr Figure 08)

This is a package of Divalproex Sodium tablets containing 30 tablets each, with a strength of 500mg. The package includes prescribing information, and the tablets are manufactured by Zydus. They should be stored at room temperature and have an expiration date of 06/08/15. This medication is only available with a prescription.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.